Industry News

Verdezyne Gets US Patent on Engineered Microorganisms

Published on 2012-01-24. Author : SpecialChem

Carlsbad, Calif. -- Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals and fuels from non-petroleum sources, has been granted a United States Patent on engineered microorganisms. Verdezyne was awarded U.S. Patent No. 8,093,037, titled "Engineered Microorganisms With Enhanced Fermentation Activity" for the company's innovative engineering of a yeast which incorporates xylose isomerase, a key enzyme in the fermentation of certain pentose ("C-5") sugars to ethanol and other products.

"Verdezyne has identified, engineered and now patented a unique class of xylose isomerases that enable yeast to ferment xylose, the primary pentose sugar in cellulosic feedstocks, to ethanol at high yields under completely anaerobic conditions," said Dr. Stephen Picataggio, chief scientific officer of Verdezyne.

"Although the technology for ethanol production from starch and sugarcane is mature, the US Renewable Fuels Standard requirements mandate an increase in the amount of cellulosic-derived ethanol to be produced," said Dr. E. William Radany, CEO of Verdezyne. "This will require efficient fermentation of C-5 sugars to be economical."

About Verdezyne

Verdezyne is an industrial biotechnology company using proven and proprietary metabolic pathway engineering tools to develop unique yeast strains for cost-effective production of bio-based chemicals and fuels. Current investors in Verdezyne include BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners and Monitor Ventures.

Source: Verdezyne

The Chemicals Sales & Marketing Toolbox
Channel Alerts

Receive weekly digests on hot topics

Back to Top